Terms: = Kidney tumors AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Diagnosis
106 results:
1. WT1 and tp53 as valuable diagnostic biomarkers for relapse after hematopoietic stem cell transplantation in acute myeloid leukemia.
Asghari-Ghomi A; Fallahian F; Garavand J; Mohammadi MH
Mol Biol Rep; 2024 Feb; 51(1):244. PubMed ID: 38300383
[TBL] [Abstract] [Full Text] [Related]
2. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
3. Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report.
Yang Y; Lee J; Woo CG; Lee OJ; Son SM
Diagn Pathol; 2024 Jan; 19(1):16. PubMed ID: 38243242
[TBL] [Abstract] [Full Text] [Related]
4. The use of Clinicopathological, immunohistochemistry and molecular detection in the diagnosis of fumarate hydratase-deficient uterine leiomyomas.
Zhang X; Wang C; Shen D
Pathol Res Pract; 2024 Jan; 253():154916. PubMed ID: 38029712
[TBL] [Abstract] [Full Text] [Related]
5. p53, CK20, and FGFR3 Overexpression is Associated with the Characteristics of Urothelial Cell Carcinoma of the Bladder.
Asgari M; Firouzi F; Abolhasani M; Bahadoram M; Barahman M; Madjd Z; Mehrazam M; Hassanzadeh S; Akade E
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3125-3131. PubMed ID: 37774064
[TBL] [Abstract] [Full Text] [Related]
6. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
Navale P; Chatterjee D; Itani M; Trikalinos NA
Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
[TBL] [Abstract] [Full Text] [Related]
7. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings.
Gama A; Xu H; Yang XJ; Choy B
Int J Surg Pathol; 2024 Feb; 32(1):11-16. PubMed ID: 37063043
[No Abstract] [Full Text] [Related]
8. miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses.
Elballal MS; Sallam AM; Elesawy AE; Shahin RK; Midan HM; Elrebehy MA; Elazazy O; El-Boghdady RM; Blasy SH; Amer NM; Farid HI; Mohammed DA; Ahmed SA; Mohamed SS; Doghish AS
Pathol Res Pract; 2023 May; 245():154439. PubMed ID: 37028108
[TBL] [Abstract] [Full Text] [Related]
9. Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma.
Zhang GT; Liu Q; Zuo FX; Liu HJ; Wang SQ; Yuan Q; Liu AS; Hu K; Meng XL; Wang WJ; Qian HP; Wan JH; Cai HQ
BMC Cancer; 2023 Jan; 23(1):104. PubMed ID: 36717819
[TBL] [Abstract] [Full Text] [Related]
10. A case of TFE3 translocation renal cell carcinoma with rare morphological features and literature review.
Xia T; Long H; Liao D; Wang W; Xiao X
Indian J Pathol Microbiol; 2023; 66(1):135-140. PubMed ID: 36656224
[TBL] [Abstract] [Full Text] [Related]
11. Clinical relevance of BCOR internal tandem duplication and tp53 aberration in clear cell sarcoma of the kidney.
Zhang M; Yao X; Guan X; Jia C; Zhang R; Wang H; Guo Y; Ni X; Yu Y; He L
Hum Pathol; 2023 Apr; 134():45-55. PubMed ID: 36563883
[TBL] [Abstract] [Full Text] [Related]
12. NFE2L3 as a Potential Functional Gene Regulating Immune Microenvironment in Human kidney Cancer.
Zhang Q; Tang D; Zha A; He J; Li D; Chen Y; Cai W; Dai J; Luan S; Yin L; Zhang W; Dai Y
Biomed Res Int; 2022; 2022():9085186. PubMed ID: 36337840
[TBL] [Abstract] [Full Text] [Related]
13. A Clinicopathological and Molecular Analysis of Fumarate Hydratase (FH)-deficient Renal Cell Carcinomas with Heterogeneous Loss of FH Expression.
Anderson WJ; Tsai HK; Sholl LM; Hirsch MS
Int J Surg Pathol; 2022 Sep; 30(6):606-615. PubMed ID: 35048731
[No Abstract] [Full Text] [Related]
14. Clinicopathological significance of claspin overexpression and its efficacy as a novel biomarker for the diagnosis of urothelial carcinoma.
Kobayashi G; Hayashi T; Sentani K; Babasaki T; Sekino Y; Inoue S; Uraoka N; Hanamoto M; Nose H; Teishima J; Oue N; Matsubara A; Sasaki N; Yasui W
Virchows Arch; 2022 Mar; 480(3):621-633. PubMed ID: 34842980
[TBL] [Abstract] [Full Text] [Related]
15. Differential immunohistochemical and molecular profiling of conventional and aggressive components of chromophobe renal cell carcinoma: pitfalls for diagnosis.
Chen CV; Croom NA; Simko JP; Stohr BA; Chan E
Hum Pathol; 2022 Jan; 119():85-93. PubMed ID: 34800526
[TBL] [Abstract] [Full Text] [Related]
16. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.
Dong Y; Ma WM; Yang W; Hao L; Zhang SQ; Fang K; Hu CH; Zhang QJ; Shi ZD; Zhang WD; Fan T; Xia T; Han CH
BMC Cancer; 2021 Oct; 21(1):1135. PubMed ID: 34688260
[TBL] [Abstract] [Full Text] [Related]
17. Anaplastic Sarcoma of the kidney With Heterologous Ganglioneuroblastic Differentiation: Another DICER1-Associated Tumor.
Kroll-Wheeler L; Heider A
Pediatr Dev Pathol; 2022; 25(2):186-191. PubMed ID: 34515577
[TBL] [Abstract] [Full Text] [Related]
18. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.
Kim J; Gianferante M; Karyadi DM; Hartley SW; Frone MN; Luo W; Robison LL; Armstrong GT; Bhatia S; Dean M; Yeager M; Zhu B; Song L; Sampson JN; Yasui Y; Leisenring WM; Brodie SA; de Andrade KC; Fortes FP; Goldstein AM; Khincha PP; Machiela MJ; McMaster ML; Nickerson ML; Oba L; Pemov A; Pinheiro M; Rotunno M; Santiago K; Wegman-Ostrosky T; Diver WR; Teras L; Freedman ND; Hicks BD; Zhu B; Wang M; Jones K; Hutchinson AA; Dagnall C; Savage SA; Tucker MA; Chanock SJ; Morton LM; Stewart DR; Mirabello L
JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 34308104
[TBL] [Abstract] [Full Text] [Related]
19. Recent Advances in Pathology: the 2021 Annual Review Issue of The Journal of Pathology.
Herrington CS; Poulsom R; Koeppen H; Coates PJ
J Pathol; 2021 Jul; 254(4):303-306. PubMed ID: 34097314
[TBL] [Abstract] [Full Text] [Related]
20. Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis.
Diez-Calzadilla NA; Noguera Salvá R; Soriano Sarrió P; Martínez-Jabaloyas JM
Cancer Treat Res Commun; 2021; 27():100374. PubMed ID: 33932757
[TBL] [Abstract] [Full Text] [Related]
[Next]
